Overview

Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage

Status:
Not yet recruiting
Trial end date:
2021-05-28
Target enrollment:
Participant gender:
Summary
1. To evaluate the effectiveness of Huperzine A injection in the treatment of brain injury in patients with hypertensive cerebral hemorrhage; 2. To evaluate the safety of Huperzine A injection in the treatment of brain injury in patients with hypertensive cerebral hemorrhage。
Phase:
Phase 4
Details
Lead Sponsor:
Jiangsu Famous Medical Technology Co., Ltd.
Treatments:
Huperzine A